Dr. Amaria on Genetically Modified TILs in Melanoma
2 Ansichten
• 07/03/23
0
0
Einbetten
administrator
Abonnenten
Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare